Choroideremia: Toward Regulatory Approval of Retinal Gene Therapy. (2023)

First Author: Yusuf IH
Attributed to:  Development of AAV gene therapy for blindness caused by cone-rod dystrophy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/cshperspect.a041279

PubMed Identifier: 37277205

Publication URI: http://europepmc.org/abstract/MED/37277205

Type: Journal Article/Review

Volume: 13

Parent Publication: Cold Spring Harbor perspectives in medicine

Issue: 12

ISSN: 2157-1422